Search

Your search keyword '"Lassègue B"' showing total 104 results

Search Constraints

Start Over You searched for: Author "Lassègue B" Remove constraint Author: "Lassègue B"
104 results on '"Lassègue B"'

Search Results

3. Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells

10. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation.

11. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid

12. The vascular angiotensin (AT1) receptor

15. Polymerase delta-interacting protein 2 mediates brain vascular permeability by regulating ROS-mediated ZO-1 phosphorylation and localization at the interendothelial border.

16. Endothelial Poldip2 regulates sepsis-induced lung injury via Rho pathway activation.

17. Myeloid Poldip2 Contributes to the Development of Pulmonary Inflammation by Regulating Neutrophil Adhesion in a Murine Model of Acute Respiratory Distress Syndrome.

18. Characterization of Poldip2 knockout mice: Avoiding incorrect gene targeting.

19. Poldip2 controls leukocyte infiltration into the ischemic brain by regulating focal adhesion kinase-mediated VCAM-1 induction.

20. β 1- and β 2-integrins: central players in regulating vascular permeability and leukocyte recruitment during acute inflammation.

22. Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy.

23. Polymerase-δ-interacting protein 2 activates the RhoGEF epithelial cell transforming sequence 2 in vascular smooth muscle cells.

24. Poldip2 knockdown inhibits vascular smooth muscle proliferation and neointima formation by regulating the expression of PCNA and p21.

25. The cofilin phosphatase slingshot homolog 1 restrains angiotensin II-induced vascular hypertrophy and fibrosis in vivo.

26. Poldip2 deficiency protects against lung edema and vascular inflammation in a model of acute respiratory distress syndrome.

27. NOX4 (NADPH Oxidase 4) and Poldip2 (Polymerase δ-Interacting Protein 2) Induce Filamentous Actin Oxidation and Promote Its Interaction With Vinculin During Integrin-Mediated Cell Adhesion.

28. Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4.

29. Poldip2 is an oxygen-sensitive protein that controls PDH and αKGDH lipoylation and activation to support metabolic adaptation in hypoxia and cancer.

30. Polymerase delta-interacting protein 2 deficiency protects against blood-brain barrier permeability in the ischemic brain.

31. Polymerase δ-interacting Protein 2: A Multifunctional Protein.

32. Cyclic Strain and Hypertension Increase Osteopontin Expression in the Aorta.

33. NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis.

34. Polymerase delta-interacting protein 2 regulates collagen accumulation via activation of the Akt/mTOR pathway in vascular smooth muscle cells.

35. Hic-5 Mediates TGFβ-Induced Adhesion in Vascular Smooth Muscle Cells by a Nox4-Dependent Mechanism.

36. Poldip2 controls vascular smooth muscle cell migration by regulating focal adhesion turnover and force polarization.

37. Polymerase δ-interacting protein 2 promotes postischemic neovascularization of the mouse hindlimb.

38. Poldip2 knockout results in perinatal lethality, reduced cellular growth and increased autophagy of mouse embryonic fibroblasts.

39. Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension.

40. Hydrogen peroxide regulates osteopontin expression through activation of transcriptional and translational pathways.

41. Transforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation.

42. Polymerase delta interacting protein 2 sustains vascular structure and function.

43. The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice.

44. Role of coronin 1B in PDGF-induced migration of vascular smooth muscle cells.

45. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

46. Vascular smooth muscle insulin resistance, but not hypertrophic signaling, is independent of angiotensin II-induced IRS-1 phosphorylation by JNK.

47. Platelet-derived growth factor (PDGF) regulates Slingshot phosphatase activity via Nox1-dependent auto-dephosphorylation of serine 834 in vascular smooth muscle cells.

48. NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor.

49. NADPH oxidases: functions and pathologies in the vasculature.

50. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells.

Catalog

Books, media, physical & digital resources